Cargando…
J147 Reduces tPA-Induced Brain Hemorrhage in Acute Experimental Stroke in Rats
BACKGROUND AND PURPOSE: J147, a novel neurotrophic compound, was originally developed to treat aging-associated neurological diseases. Based on the broad spectrum of cytoprotective effects exhibited by this compound, we investigated whether J147 has cerebroprotection for acute ischemic stroke and wh...
Autores principales: | Jin, Rong, Wang, Min, Zhong, Wei, Kissinger, Charles R., Villafranca, J. Ernest, Li, Guohong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925862/ https://www.ncbi.nlm.nih.gov/pubmed/35309561 http://dx.doi.org/10.3389/fneur.2022.821082 |
Ejemplares similares
-
Treatment of stroke in aged male and female rats with Vepoloxamer and tPA reduces neurovascular damage
por: Zhang, Li, et al.
Publicado: (2023) -
Inhibition of CD147 Attenuates Stroke-Associated Pneumonia Through Modulating Lung Immune Response in Mice
por: Jin, Rong, et al.
Publicado: (2019) -
Intravenous thrombolysis with 0.65 mg/kg r-tPA may be optimal for Chinese mild-to-moderate stroke
por: Cui, Yu, et al.
Publicado: (2022) -
Synergy of Combined tPA-Edaravone Therapy in Experimental Thrombotic Stroke
por: Sun, Yu-Yo, et al.
Publicado: (2014) -
tPA or not tPA? Lysis therapy in the setting of COVID‐19 and ECMO
por: Cromartie, Anjelica, et al.
Publicado: (2022)